Insulet
PODD
#1343
Rank
NZ$27.82 B
Marketcap
NZ$395.27
Share price
0.28%
Change (1 day)
-12.00%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2025 (TTM): NZ$6.10

According to Insulet's latest financial reports the company's current EPS (TTM) is NZ$5.99. In 2024 the company made an earnings per share (EPS) of NZ$10.23 an increase over its 2023 EPS that were of NZ$5.04.

EPS history for Insulet from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$6.10-40.35%
2024NZ$10.23102.71%
2023NZ$5.044114.29%
2022NZ$0.12-69.57%
2021NZ$0.39109.09%
2020NZ$0.19-38.89%
2019NZ$0.31200%
2018NZ$0.10-113.04%
2017NZ-$0.79-9.8%
2016NZ-$0.87-60.47%
2015NZ-$2.2138.71%
2014NZ-$1.5912.05%
2013NZ-$1.42-23.15%
2012NZ-$1.85-12.2%
2011NZ-$2.10

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$19.05 218.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.41 7.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$6.34 6.00%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$39.37 557.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
NZ-$5.22-187.14%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
NZ-$0.53-108.86%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
NZ$3.16-47.14%๐Ÿ‡บ๐Ÿ‡ธ USA